Medications

The pharmaceutical ethics of stunning drug-price increases

Last week Turing Pharmaceuticals, a startup run by a former hedge-fund manager, raised the price of Daraprim—the standard treatment for toxoplasmosis—from $13.50 to $750 a tablet soon after acquiring the drug from another ...

Medications

Does America have the cure for high drug costs?

Soaring prices for everything from cancer treatments to hepatitis C pills that cost more than $100,000 have sparked outcry in the United States in recent years, but calls for change have gone largely unheeded.

Medications

Valeant steps in to work on psoriasis drug with AstraZeneca

Canadian drugmaker Valeant will work with British competitor AstraZeneca on a potential treatment for psoriasis a few months after biotech giant Amgen said it was ending research on the drug because of a link to suicidal ...

Diseases, Conditions, Syndromes

Phase II trials underway for new single dose malaria treatment

Early research on a new malaria drug shows potential for a single dose treatment of the disease. The new drug, which prevents the malaria parasite from reproducing and spreading, is now undergoing Phase II clinical trials ...

Medications

FDA clears drug for leading form of cystic fibrosis

Federal health officials have approved a new combination drug for the most common form of cystic fibrosis, the debilitating inherited disease that causes internal mucus buildup, lung infections and early death. But it will ...

Medications

California court sides with consumers in generic drug fight

In a win for consumers, the California Supreme Court ruled Thursday that settlement agreements between pharmaceutical companies that keep cheaper, generic drugs off the market may be illegal if they include excessive cash ...

page 32 from 40